Ning Liu

发表

ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma

Yahui Ding, Xiaonan Xi, Ning Liu, 2019, Cell Death & Disease.

Effects of K5SiW11O39Co on Mitogenic Activity of Basic Fibroblast Growth Factor

Liwei Sun, Daqing Zhao, Ning Liu, 2004 .

5α-Epoxyalantolactone Inhibits Metastasis of Triple-Negative Breast Cancer Cells by Covalently Binding a Conserved Cysteine of Annexin A2.

Xiang Liu, Cheng Lu, Guang Yang, 2021, Journal of medicinal chemistry.

Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma

Yue-hua Chen, Xiaonan Xi, Ning Liu, 2019, Journal of Translational Medicine.

Establishment of a Customizable Fluorescent Probe Platform for the Organelle-targeted Bioactive Species Detection.

Xijing Liang, Lu Zhang, Luqing Shang, 2020, ACS sensors.

A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway.

Honggang Zhou, Cheng Lu, Guang Yang, 2018, European journal of medicinal chemistry.

Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability.

M. Volgraf, A. Ebens, John G. Moffat, 2017, Journal of medicinal chemistry.

Pharmacokinetics, tissue distribution and excretion of ACT001 in Sprague-Dawley rats and metabolism of ACT001.

Linlin Wang, Yue-hua Chen, Xiaonan Xi, 2019, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Natural Product Micheliolide (MCL) Irreversibly Activates Pyruvate Kinase M2 and Suppresses Leukemia

M. Luo, P. Wang, Chunli Yan, 2018, Journal of medicinal chemistry.

Application of Dually Activated Michael Acceptor to the Rational Design of Reversible Covalent Inhibitor for Enterovirus 71 3C Protease.

Luqing Shang, Yaxin Wang, T. Meek, 2019, Journal of medicinal chemistry.

Design and optimization of novel hydroxamate-based histone deacetylase inhibitors of Bis-substituted aromatic amides bearing potent activities against tumor growth and metastasis.

Tao Zhang, Mingyao Liu, Xiufeng Pang, 2014, Journal of medicinal chemistry.

Proteolysis-Targeting Chimera (PROTAC) Modification of Dovitinib Enhances the Antiproliferative Effect against FLT3-ITD-Positive Acute Myeloid Leukemia Cells.

Guang Yang, Cheng Yang, Xiaoji Wang, 2021, Journal of medicinal chemistry.

Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-β1 pathway.

Honggang Zhou, Cheng Lu, Zhun Bi, 2018, European journal of medicinal chemistry.

Structure-Guided Design of Group I Selective p21-Activated Kinase Inhibitors.

I. Aliagas, K. Hoeflich, Weiru Wang, 2015, Journal of medicinal chemistry.

Structure optimization and discovery of novel compound for the treatment of insertion mutations within exon 20 of EGFR and HER2.

L. Zuo, Guang Yang, Fei Hou, 2023, Bioorganic & medicinal chemistry.

Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma

Yue-hua Chen, Xiaonan Xi, Ning Liu, 2019, Journal of Translational Medicine.

LG308, a Novel Synthetic Compound with Antimicrotubule Activity in Prostate Cancer Cells, Exerts Effective Antitumor Activity

Mingyao Liu, Yuan He, Yundong He, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Targeted Drug-Loaded Chemical Probe Staining Assay to Predict Therapy Response and Function as an Independent Pathological Marker

Honggang Zhou, Wei-long Zhong, Bo Sun, 2019, iScience.

Discovery and Optimization of a Novel 2H-Pyrazolo[3,4-d]pyrimidine Derivative as a Potent Irreversible Pan-Fibroblast Growth Factor Receptor Inhibitor.

Honggang Zhou, Guang Yang, Cheng Yang, 2021, Journal of medicinal chemistry.

Design and optimization of novel hydroxamate-based histone deacetylase inhibitors of Bis-substituted aromatic amides bearing potent activities against tumor growth and metastasis.

Tao Zhang, Mingyao Liu, Xiufeng Pang, 2014, Journal of medicinal chemistry.

Structure-Guided Design of Group I Selective p21-Activated Kinase Inhibitors.

I. Aliagas, K. Hoeflich, Weiru Wang, 2015, Journal of medicinal chemistry.

Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.

Honggang Zhou, Cheng Lu, Guang Yang, 2018, Journal of Medicinal Chemistry.